PTC Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. Welcome to Barclays Global Healthcare Conference. It is my great pleasure to introduce our first presenting company, PTC Therapeutics. With us today, we have Matthew Klein, Chief Operating Officer; and also Kylie O'Keefe, SVP, Commercial and a Corporate Strategy.
So before I start, Matthew and Kylie, do you want to give a quick overview of the company? And then we can dive into the questions.
Sure. Thanks, Gena. Thank you so much for this opportunity to present today. For those of you who don't know PTC, we're a global biopharmaceutical company that discovers, develops and commercializes innovative therapies for rare disorders. We have a broad platform built on a number of different pioneering scientific platforms. And also with multiple different scientific approaches, including targeting gene -- [Bio-e] gene therapy, RNA technology and others. We had a very successful 2021 from a commercial standpoint with net
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
